Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lenus Pharma is a Vienna-based pharmaceutical company dedicated to the development and global distribution of evidence-based nutraceuticals, with a primary focus on reproductive medicine. The company is widely recognized for its flagship product, PROfertil, a patented formulation clinically proven to improve sperm quality in men with impaired fertility. In addition to male reproductive health, Lenus Pharma provides targeted nutritional solutions for women, addressing fertility challenges related to polycystic ovary syndrome (PCOS) and pregnancy preparation. By emphasizing clinical research and high-quality manufacturing standards, the company positions its products as therapeutic options within the urology and gynecology sectors. Lenus Pharma operates internationally, exporting its specialized health products to over 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lenus Pharma.